Measles Vaccine Virus RNA in Children More Than 100 Days after Vaccination

• Published in: Viruses Vol. 11; no. 7; p. 636
• Main Authors: McMahon, Jamie, Mackay, Ian M, Lambert, Stephen B
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10.07.2019; MDPI
• Subjects: Australia; Child, Preschool; Children; Communication; Ethics; Female; Genotype & phenotype; Genotyping; Health surveillance; Humans; Illnesses; Infant; Laboratories; Male; Maximum likelihood method; Measles; Measles - prevention & control; Measles - virology; measles vaccine; Measles Vaccine - administration & dosage; measles virus; Measles virus - genetics; measles-mumps-rubella; N gene; Nose - virology; persistence; Pharynx - virology; Phosphoproteins - genetics; Phylogenetics; Phylogeny; Polymerase chain reaction; Public health; Respiratory System - virology; Respiratory tract; Reverse transcription; Ribonucleic acid; RNA; RNA viruses; RNA, Viral - analysis; RT-PCR; Time Factors; vaccine safety; Vaccines; Viral Proteins - genetics; Viruses; Australia; Queensland Australia; United States > US; Germany; New South Wales Australia; vaccine safety; RNA; vaccines; RT-PCR; persistence; measles vaccine; measles-mumps-rubella; measles; measles virus

Measles vaccines have been in use since the 1960s with excellent safety and effectiveness profiles. Limited data are available on detection of measles vaccine virus (MeVV) RNA in human subjects following vaccination. Available evidence suggests MeVV RNA can be identified up to 14 days after vaccinat...